ECML
PFE icon

Eagle Capital Management (Louisiana)’s Pfizer PFE Stock Holding History

Eagle Capital Management (Louisiana)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
126,581
+8
+0% +$209 1.04% 24
2026
Q1 		$3.55M Buy
126,573
+390
+0.3% +$10.4K 1.4% 22
2025
Q4 		$3.14M Sell
126,183
-5,208
-4% -$131K 1.14% 25
2025
Q3 		$3.35M Buy
131,391
+4,990
+4% +$123K 1.27% 25
2025
Q2 		$3.06M Buy
126,401
+1,257
+1% +$29.3K 1.35% 23
2025
Q1 		$3.17M Sell
125,144
-680
-0.5% -$17.8K 1.4% 23
2024
Q4 		$3.34M Sell
125,824
-755
-0.6% -$20.5K 1.35% 23
2024
Q3 		$3.66M Buy
126,579
+425
+0.3% +$12.4K 1.53% 23
2024
Q2 		$3.53M Buy
126,154
+150
+0.1% +$4.13K 1.56% 23
2024
Q1 		$3.5M Buy
126,004
+1,056
+0.8% +$29.3K 1.57% 23
2023
Q4 		$3.6M Buy
+124,948
New +$3.78M 1.75% 19
2019
Q3 		– Sell
-89,250
Closed -$3.67M – 37
2019
Q2 		$3.67M Buy
89,250
+1,186
+1% +$47.1K 1.99% 20
2019
Q1 		$3.55M Sell
88,064
-479
-0.5% -$19.2K 2.08% 19
2018
Q4 		$3.67M Sell
88,543
-470
-0.5% -$19.5K 2.76% 12
2018
Q3 		$3.72M Buy
89,013
+1,236
+1% +$47.6K 2.1% 17
2018
Q2 		$3.02M Buy
87,777
+352
+0.4% +$12K 1.9% 24
2018
Q1 		$2.94M Sell
87,425
-820
-0.9% -$28.2K 2.06% 24
2017
Q4 		$3.03M Sell
88,245
-279
-0.3% -$9.51K 1.63% 25
2017
Q3 		$3M Sell
88,524
-291
-0.3% -$9.35K 1.71% 24
2017
Q2 		$2.83M Sell
88,815
-1,123
-1% -$35.4K 1.68% 27
2017
Q1 		$2.92M Buy
+89,938
New +$2.84M 1.79% 15

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Eagle Capital Management (Louisiana)'s PFE Position: Q2 2026 in Review

Eagle Capital Management (Louisiana) increased its Pfizer (PFE) stake by 0.01% in Q2 2026, buying an estimated $209 and bringing the position to 126,581 shares worth $3.05M. The position accounts for 1.04% of the portfolio, ranked #24.

Eagle Capital Management (Louisiana) first reported a position in PFE in Q1 2017 and has held it in 21 quarters since. The position peaked at $3.72M in Q3 2018. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Eagle Capital Management (Louisiana) held 126,581 shares of Pfizer worth $3.05M as of Q2 2026.
  • Eagle Capital Management (Louisiana) bought 8 Pfizer shares in Q2 2026, an estimated $209.
  • Pfizer made up 1.04% of Eagle Capital Management (Louisiana)'s portfolio in Q2 2026, its #24 holding.
  • Eagle Capital Management (Louisiana) first reported a position in Pfizer in Q1 2017 and has held it in 21 quarters since.
  • Eagle Capital Management (Louisiana)'s Pfizer position peaked at $3.72M in Q3 2018.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Eagle Capital Management (Louisiana)'s 13F filing for Q2 2026, filed 13 Jul 2026.